HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French OTC Industry Warns Over-Regulation Is Threatening Its Future

Executive Summary

Plans to move ibuprofen, aspirin and paracetamol OTCs behind the counter in French pharmacies will harm the country's self-medication industry, which is already lagging behind its European neighbors, warns local association Afipa.

You may also be interested in...



French OTC Industry Frustrated By Regulatory Clampdown in 2019

Speaking exclusively to HBW Insight, French OTC association Afipa reflects on a difficult 2019 which saw tighter restrictions introduced on the sale of popular consumer health products. The trade group believes the industry's best prospects for a brighter future are rebuilding relations with national drug regulator ANSM and to getting self-care higher up the agenda of the French government.

France Orders On-Pack Warnings For Paracetamol Over Liver Damage Fears

Fears over misuse mean all paracetamol-containing products (also known as acetaminophen) sold in France will from next year be required to carry prominent on-pack warnings.

France Reverse-Switches Flurbiprofen Against Backdrop Of NSAID Concerns

France has unexpectedly reverse switched to prescription status flurbiprofen, the active ingredient in Reckitt's Strefen. The move comes shortly after the country's medicines agency warned of serious adverse events related to certain NSAIDs.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS149286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel